Alison Center | BioProcess International

Alison Center

Latest from Alison Center

eBook: mRNA — Revisiting a Technology That Has Rocketed into Success

eBook: mRNA — Revisiting a Technology That Has Rocketed into Success eBook: mRNA — Revisiting a Technology That Has Rocketed into Success

byAlison Center, S. Anne Montgomeryand 4 more

Apr 28, 2021

Monoclonal Antibodies: Beyond the Platform in Manufacturing

Monoclonal Antibodies: Beyond the Platform in Manufacturing Monoclonal Antibodies: Beyond the Platform in Manufacturing

byAlison Center, Cheryl Scott

Mar 29, 2019

All from Alison Center

Continuous Chromatography: Experts Weigh in on the Possibilities and the Reality

Continuous Bioprocessing

Continuous Chromatography: Experts Weigh in on the Possibilities and the Reality

Continuous Chromatography: Experts Weigh in on the Possibilities and the Reality

+1

byS. Anne Montgomery, Cheryl Scottand 1 more

Messenger RNA Drugs: Engaging the Machinery of Patients' Cells to Therapeutic Effect

Messenger RNA Drugs: Engaging the Machinery of Patients' Cells to Therapeutic Effect

Messenger RNA Drugs: Engaging the Machinery of Patients' Cells to Therapeutic Effect

byAlison Center, S. Anne Montgomery

Regulatory Affairs

Innovators and Biosimilar Companies: Experts Predict Intense Conflicts Ahead

Innovators and Biosimilar Companies: Experts Predict Intense Conflicts Ahead

byAlison Center

Facilities of the Future: Intelligent Design and Control Enable Quality, Efficiency, and Good Citizenship

Facility Design/Engineering

Facilities of the Future: Intelligent Design and Control Enable Quality, Efficiency, and Good Citizenship

Facilities of the Future: Intelligent Design and Control Enable Quality, Efficiency, and Good Citizenship

byAlison Center

Panel Discussion: Emerging Biotherapies and Their Manufacturing Challenges

Sponsored Content

Panel Discussion: Emerging Biotherapies and Their Manufacturing Challenges

Panel Discussion: Emerging Biotherapies and Their Manufacturing Challenges

byAlison Center

Panel Discussion: How CMO Business Models Have Adapted to Meet the Challenges and Opportunities of Protein-Based and Emerging Therapy Markets

Sponsored Content

Panel Discussion: How CMO Business Models Have Adapted to Meet the Challenges and Opportunities of Protein-Based and Emerging Therapy Markets

Panel Discussion: How CMO Business Models Have Adapted to Meet the Challenges and Opportunities of Protein-Based and Emerging Therapy Markets

byAlison Center

Panel Discussion: Cell, Gene, and Tissue Therapies — Applying Key Lessons from the Evolution and Commercialization of Protein-Based Therapies

Sponsored Content

Panel Discussion: Cell, Gene, and Tissue Therapies — Applying Key Lessons from the Evolution and Commercialization of Protein-Based Therapies

Panel Discussion: Cell, Gene, and Tissue Therapies — Applying Key Lessons from the Evolution and Commercialization of Protein-Based Therapies

byAlison Center

Panel Discussion: Process and Business Considerations for Innovation — Supplier and End-User Perspectives

Sponsored Content

Panel Discussion: Process and Business Considerations for Innovation — Supplier and End-User Perspectives

Panel Discussion: Process and Business Considerations for Innovation — Supplier and End-User Perspectives

byAlison Center

Panel Discussion: Single-Use and Process Development Technologies — Making the Right Choices for Your Process

Sponsored Content

Panel Discussion: Single-Use and Process Development Technologies — Making the Right Choices for Your Process

Panel Discussion: Single-Use and Process Development Technologies — Making the Right Choices for Your Process

byAlison Center

Panel Discussion: How to Differentiate Your Vaccine Platform in a Competitive Market

Sponsored Content

Panel Discussion: How to Differentiate Your Vaccine Platform in a Competitive Market

Panel Discussion: How to Differentiate Your Vaccine Platform in a Competitive Market

byAlison Center

Viral Clearance

Current Thinking in Viral Safety: Risk Management Protects Patients

Current Thinking in Viral Safety: Risk Management Protects Patients

+1

byHazel Aranha, S. Anne Montgomeryand 1 more

Going After a Moving Target: New Production Methods Aid in the Flu Fight

Going After a Moving Target: New Production Methods Aid in the Flu Fight

byCheryl Scott, Alison Center

Rapid Development of High-Quality, Robust Mammalian Cell Culture Manufacturing Processes

Process Development

Rapid Development of High-Quality, Robust Mammalian Cell Culture Manufacturing Processes

Rapid Development of High-Quality, Robust Mammalian Cell Culture Manufacturing Processes

byJozef Orpiszewski, Alison Center

Deciding Between Single-Use and Stainless Steel Strategies

Sponsored Content

Deciding Between Single-Use and Stainless Steel Strategies

Deciding Between Single-Use and Stainless Steel Strategies

+4

byAlison Center, Eric S. Langerand 4 more

Coordination of Single-Use System Standards and Best-Practice Efforts

Sponsored Content

Coordination of Single-Use System Standards and Best-Practice Efforts

Coordination of Single-Use System Standards and Best-Practice Efforts

+2

byAlison Center, James Vogeland 2 more

Getting the Most in Training for New Technologies

Sponsored Content

Getting the Most in Training for New Technologies

Getting the Most in Training for New Technologies

+4

byAlison Center, Brian Caineand 4 more

Industrialization and Commercialization of Gene and Cell Therapies

Sponsored Content

Industrialization and Commercialization of Gene and Cell Therapies

Industrialization and Commercialization of Gene and Cell Therapies

+4

byAlison Center, Mike Wardand 4 more

Making the Correct Outsourcing Decisions

Sponsored Content

Making the Correct Outsourcing Decisions

Making the Correct Outsourcing Decisions

+4

byAlison Center, Gil Rothand 4 more

Subscribe to receive our monthly print or digital publication

Join our 70,000+ readers. And yes, it's completely free.